Not All Sulfa Drugs Are Created Equal

1. Petri WA . Antimicrobial agents. Sulfonamides, trimethoprim-sulfamethoxazole, quinolones, and agents of urinary tract infections. In: Hardman JE , Limbird LE , eds. Goodman & Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill, 2001:1171–88.

2. Bigby M , Jick S , Jick H , Arndt K . Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986; 256: 3358–63. DOI 10.1001/jama.256.24.3358

3. Naldi L , Conforti A , Venegoni M , Troncon MG , Caputi A , Ghiotto E , Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br J Clin Pharmacol 1999; 48: 839–46. DOI 10.1046/j.1365-2125.1999.00096.x

4. Physicians' desk reference. 57th ed. Montvale, NJ: Medical Economics, 2003.

5. Knowles S , Shapiro L , Shear NH . Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of “sulfa” allergy. Drug Saf 2001; 24: 239–47.

6. Depta JP , Pichler WJ . Cross-reactivity with drugs at the T cell level. Curr Opin Allergy Clin Immunol 2003; 3: 261–7. DOI 10.1097/00130832-200308000-00005

7. Schnyder B , Mauri-Hellweg D , Zanni M , Bettens F , Pichler WJ . Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alpha beta T cell clones. J Clin Invest 1997; 100: 136–41.

8. Strom BL , Schinnar R , Apter AJ , Margolis DJ , Lautenbach E , Hennessy S , Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med 2003; 349: 1628–35. DOI 10.1056/NEJMoa022963

9. Shapiro LE , Knowles SR , Weber E , Neuman MG , Shear NH . Safety of celecoxib in individuals allergic to sulfonamide: a pilot study. Drug Saf 2003; 26: 187–95.

10. Patterson R , Bello AE , Lefkowith J . Immunologic tolerability profile of celecoxib. Clin Ther 1999; 21: 2065–79. DOI 10.1016/S0149-2918(00)87238-0

11. Roujeau JC , Kelly JP , Naldi L , Rzany B , Stern RS , Anderson T , Medication use and the risk of Stevens–Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333: 1600–7. DOI 10.1056/NEJM199512143332404

12. Naisbitt DJ , Hough SJ , Gill HJ , Pirmohamed M , Kitteringham NR , Park BK . Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity. Br J Pharmacol 1999; 126: 1393–407.

13. Reilly TP , Lash LH , Doll MA , Hein DW , Woster PM , Svensson CK . A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J Invest Dermatol 2000; 114: 1164–73. DOI 10.1046/j.1523-1747.2000.00985.x

14. Raffensperger C , Schettler T , Myers N . Precaution: belief, regulatory system, and overreaching principle. Int J Occup Envir Health 2000; 6: 266–9.